Excedrin Put in Review

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK Bristol-Myers Squibb has launched a review of its Excedrin creative account following Bozell’s resignation of the business, sources said.

The pharmaceutical and health-care products marketer is hearing presentations this week from New York-based roster shops Bates and Gotham for the pain-relief medication, according to sources. It is unclear if other shops are involved. The New York-based company put $25 million in measured media behind the brand for the first nine months of this year, half of what it spent for full year 2001, per CMR.

Bozell



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Spring Special

Save 30% Off an ADWEEK Subscription Today!

View Your Options

Already a member? Sign in